V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001177 | 240010614 | 1.59 | 95 | null | null | 2018-04-04 | Rituximab | null | null | RITUXIMAB | 101265711 |
| 240001181 | 240010616 | null | null | null | 2021-06-08 | 2021-06-18 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 101233501 |
| 240001185 | 240010618 | 1.68 | 0 | Palliative (P) | null | 2018-11-07 | null | 02 | null | RITUXIMAB | 100436981 |
| 240001191 | 240010620 | 1.73 | 116.5 | null | null | 2017-05-23 | null | 02 | null | AML18 TRIAL | 100073400 |
| 240001199 | 240010621 | 1.85 | 60.8 | null | null | 2017-10-19 | Rituximab | 02 | null | RITUXIMAB | 100674767 |
| 240001204 | 240010624 | 1.56 | 53.9 | Palliative (P) | null | 2019-12-07 | null | 02 | null | AML18 TRIAL | 101606493 |
| 240001209 | 240010627 | 1.56 | 71.5 | null | null | 2020-01-05 | Rituximab (Maintenance) | null | null | RITUXIMAB | 100061251 |
| 240001211 | 240010628 | 1.65 | 92.8 | null | 2020-04-11 | 2020-04-17 | Hydroxycarbamide | N | null | HYDROXYCARBAMIDE | 100408273 |
| 240001215 | 240010629 | 1.65 | 89.2 | 03 | null | 2019-02-25 | null | null | N | AML18 TRIAL | 100529520 |
| 240001216 | 240010630 | 1.7 | 46.2 | Adjuvant (A) | 2020-10-09 | 2020-11-05 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101790471 |
| 240001217 | 240010631 | 1.56 | 68 | null | null | 2020-02-10 | null | null | null | AML19 TRIAL | 101496343 |
| 240001218 | 240010632 | 1.62 | 90.84 | null | 2016-03-13 | 2016-03-16 | Rituximab | 02 | null | RITUXIMAB | 100712909 |
| 240001231 | 240010638 | 1.7 | 62.3 | 03 | 2018-08-11 | 2018-08-11 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100847367 |
| 240001234 | 240010639 | 1.54 | 91 | null | 2016-07-20 | 2016-08-24 | AML 18 TRIAL | null | null | AML18 TRIAL | 101141308 |
| 240001248 | 240010642 | null | null | 03 | 2020-02-10 | 2020-02-15 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100506004 |
| 240001255 | 240010644 | 1.78 | 73.65 | Curative (C) | null | 2018-02-17 | null | null | null | RITUXIMAB | 100575047 |
| 240001262 | 240010647 | 1.53 | 70.1 | null | 2017-12-07 | 2017-12-07 | Rituximab | N | null | RITUXIMAB | 100963728 |
| 240001272 | 240010651 | 1.64 | 46.8 | null | null | 2022-03-27 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 101845502 |
| 240001274 | 240010652 | null | null | Palliative (P) | 2019-01-29 | 2019-01-31 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100221957 |
| 240001275 | 240010653 | 1.67 | 65.2 | null | null | 2019-10-25 | null | 02 | null | AML18 TRIAL | 100557855 |
| 240001281 | 240010656 | 1.81 | 57.9 | null | null | 2016-11-26 | null | N | N | CHOP R | 100740379 |
| 240001289 | 240010658 | 1.74 | 101 | Adjuvant (A) | null | 2018-12-09 | null | 02 | null | AML18 TRIAL | 100756944 |
| 240001305 | 240010663 | 1.7 | 85 | null | null | 2020-02-13 | null | 02 | null | METHOTREXATE | 101121583 |
| 240001319 | 240010665 | 1.65 | 23.2 | Curative (C) | null | 2019-05-16 | null | N | null | HYDROXYCARBAMIDE | 101043596 |
| 240001326 | 240010666 | 1.78 | 91.95 | 03 | 2021-08-01 | 2021-08-01 | CYTARABINE | 02 | null | CYTARABINE | 101116854 |
| 240001343 | 240010671 | 1.63 | 83.4 | 03 | null | 2019-09-22 | null | null | N | RITUXIMAB | 101720674 |
| 240001349 | 240010673 | 1.63 | 60.6 | null | null | 2018-06-13 | AML 18 TRIAL | null | null | AML19 TRIAL | 101393881 |
| 240001350 | 240010674 | 1.64 | 43.6 | Adjuvant (A) | null | 2021-05-23 | null | 02 | null | AZACITIDINE | 100386739 |
| 240001367 | 240010678 | 1.89 | 81.6 | null | null | 2019-01-01 | null | null | null | AZACITIDINE | 101133870 |
| 240001383 | 240010682 | 1.8 | 62.9 | null | 2020-07-01 | 2020-07-01 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 100365425 |
| 240001430 | 240010686 | 1.12 | 76.5 | Adjuvant (A) | null | 2020-03-15 | null | null | N | METHOTREXATE | 101367622 |
| 240001434 | 240010687 | 1.65 | 65 | null | null | 2019-08-12 | null | 02 | N | CYTARABINE | 100265857 |
| 240001446 | 240010689 | 1.68 | 71.1 | Neo-adjuvant (N) | 2019-05-29 | 2019-05-29 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101056794 |
| 240001458 | 240010690 | 1.67 | 46.2 | null | 2022-03-12 | 2022-04-28 | AML 18 TRIAL | null | null | CYTARABINE | 100801410 |
| 240001463 | 240010691 | null | null | null | null | 2020-10-01 | null | null | N | BENDAMUSTINE + RITUXIMAB | 101202407 |
| 240001468 | 240010693 | 1.17 | null | null | 2020-08-25 | 2020-10-30 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100515500 |
| 240001478 | 240010694 | 1.72 | 0 | Disease modification (D) | null | 2020-05-04 | null | null | null | AZACITIDINE | 101465867 |
| 240001479 | 240010695 | 1.91 | 65.4 | Curative (C) | null | 2018-10-22 | null | null | null | BENDAMUSTINE + RITUXIMAB | 100578309 |
| 240001487 | 240010696 | 1.69 | 86.7 | Curative (C) | 2018-08-10 | 2018-09-11 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | RITUXIMAB | 100399252 |
| 240001517 | 240010698 | 1.92 | 86.9 | null | null | 2019-04-13 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 100814848 |
| 240001521 | 240010699 | 1.89 | 83.4 | Curative (C) | null | 2017-07-05 | null | null | null | CHOP R | 100731628 |
| 240001525 | 240010700 | 1.83 | 26.1 | null | null | 2019-01-08 | null | null | null | BENDAMUSTINE + RITUXIMAB | 101430017 |
| 240001546 | 240010705 | 1.52 | 22.3 | null | 2019-05-15 | 2019-05-22 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101278805 |
| 240001588 | 240010709 | 1.06 | 52.4 | null | null | 2020-04-11 | null | null | null | METHOTREXATE | 100106474 |
| 240001596 | 240010710 | 1.77 | 65.9 | Curative (C) | null | 2018-10-03 | null | 02 | N | CYTARABINE | 101751354 |
| 240001607 | 240010713 | 1.77 | 46.2 | null | null | 2020-12-30 | null | 02 | null | AML18 TRIAL | 101050569 |
| 240001622 | 240010714 | 1.91 | 65.4 | Curative (C) | null | 2022-05-26 | null | N | null | RITUXIMAB | 101626772 |
| 240001661 | 240010717 | 1.6 | 65.9 | null | 2019-09-20 | 2019-09-20 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100464255 |
| 240001667 | 240010718 | 1.78 | 80.1 | 03 | null | 2022-05-01 | null | N | N | TRIAL UNSPECIFIED | 101239835 |
| 240001749 | 240010719 | 1.59 | 66.4 | null | null | 2018-11-17 | null | null | null | RITUXIMAB | 101345435 |